229 related articles for article (PubMed ID: 29359063)
21. Selective loss of cortical endothelial tight junction proteins during Alzheimer's disease progression.
Yamazaki Y; Shinohara M; Shinohara M; Yamazaki A; Murray ME; Liesinger AM; Heckman MG; Lesser ER; Parisi JE; Petersen RC; Dickson DW; Kanekiyo T; Bu G
Brain; 2019 Apr; 142(4):1077-1092. PubMed ID: 30770921
[TBL] [Abstract][Full Text] [Related]
22. The role of neurovascular unit damage in the occurrence and development of Alzheimer's disease.
Liu X; Hou D; Lin F; Luo J; Xie J; Wang Y; Tian Y
Rev Neurosci; 2019 Jul; 30(5):477-484. PubMed ID: 30530893
[TBL] [Abstract][Full Text] [Related]
23. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
Roy S; Rauk A
Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
[TBL] [Abstract][Full Text] [Related]
24. Alzheimer's Disease Prevention and Treatment: Case for Optimism.
Volloch V; Olsen B; Rits S
Ann Integr Mol Med; 2020; 2(1):115-130. PubMed ID: 33043322
[TBL] [Abstract][Full Text] [Related]
25. Comparison of cerebrospinal fluid, plasma and neuroimaging biomarker utility in Alzheimer's disease.
Meeker KL; Luckett PH; Barthélemy NR; Hobbs DA; Chen C; Bollinger J; Ovod V; Flores S; Keefe S; Henson RL; Herries EM; McDade E; Hassenstab JJ; Xiong C; Cruchaga C; Benzinger TLS; Holtzman DM; Schindler SE; Bateman RJ; Morris JC; Gordon BA; Ances BM
Brain Commun; 2024; 6(2):fcae081. PubMed ID: 38505230
[TBL] [Abstract][Full Text] [Related]
26. Testing and disclosures related to amyloid imaging and Alzheimer's disease: Common questions and fact sheet summary.
Rabinovici GD; Karlawish J; Knopman D; Snyder HM; Sperling R; Carrillo MC
Alzheimers Dement; 2016 Apr; 12(4):510-5. PubMed ID: 27103054
[TBL] [Abstract][Full Text] [Related]
27. Acute neuropathological consequences of short-term mechanical ventilation in wild-type and Alzheimer's disease mice.
Lahiri S; Regis GC; Koronyo Y; Fuchs DT; Sheyn J; Kim EH; Mastali M; Van Eyk JE; Rajput PS; Lyden PD; Black KL; Ely EW; D Jones H; Koronyo-Hamaoui M
Crit Care; 2019 Feb; 23(1):63. PubMed ID: 30795776
[TBL] [Abstract][Full Text] [Related]
28. Sporadic Alzheimer's disease begins as episodes of brain ischemia and ischemically dysregulated Alzheimer's disease genes.
Pluta R; Jabłoński M; Ułamek-Kozioł M; Kocki J; Brzozowska J; Januszewski S; Furmaga-Jabłońska W; Bogucka-Kocka A; Maciejewski R; Czuczwar SJ
Mol Neurobiol; 2013 Dec; 48(3):500-15. PubMed ID: 23519520
[TBL] [Abstract][Full Text] [Related]
29. Role of the metabolism of branched-chain amino acids in the development of Alzheimer's disease and other metabolic disorders.
Polis B; Samson AO
Neural Regen Res; 2020 Aug; 15(8):1460-1470. PubMed ID: 31997805
[TBL] [Abstract][Full Text] [Related]
30. The Neurovascular Unit Dysfunction in Alzheimer's Disease.
Soto-Rojas LO; Pacheco-Herrero M; Martínez-Gómez PA; Campa-Córdoba BB; Apátiga-Pérez R; Villegas-Rojas MM; Harrington CR; de la Cruz F; Garcés-Ramírez L; Luna-Muñoz J
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670754
[TBL] [Abstract][Full Text] [Related]
31. Canine Cognitive Dysfunction and Alzheimer's Disease - Two Facets of the Same Disease?
Prpar Mihevc S; Majdič G
Front Neurosci; 2019; 13():604. PubMed ID: 31249505
[TBL] [Abstract][Full Text] [Related]
32. The antimicrobial protection hypothesis of Alzheimer's disease.
Moir RD; Lathe R; Tanzi RE
Alzheimers Dement; 2018 Dec; 14(12):1602-1614. PubMed ID: 30314800
[TBL] [Abstract][Full Text] [Related]
33. Human amyloid-β enriched extracts: evaluation of in vitro and in vivo internalization and molecular characterization.
Pedrero-Prieto CM; Flores-Cuadrado A; Saiz-Sánchez D; Úbeda-Bañón I; Frontiñán-Rubio J; Alcaín FJ; Mateos-Hernández L; de la Fuente J; Durán-Prado M; Villar M; Martínez-Marcos A; Peinado JR
Alzheimers Res Ther; 2019 Jun; 11(1):56. PubMed ID: 31253170
[TBL] [Abstract][Full Text] [Related]
34. The Post-amyloid Era in Alzheimer's Disease: Trust Your Gut Feeling.
Osorio C; Kanukuntla T; Diaz E; Jafri N; Cummings M; Sfera A
Front Aging Neurosci; 2019; 11():143. PubMed ID: 31297054
[TBL] [Abstract][Full Text] [Related]
35. A Review on Tau Targeting Biomimetics Nano Formulations: Novel Approach for Targeting Alzheimer's Diseases.
Singh A; Maheshwari S; Yadav JP; Varshney AP; Singh S; Prajapati BG
Cent Nerv Syst Agents Med Chem; 2024 Mar; ():. PubMed ID: 38646682
[TBL] [Abstract][Full Text] [Related]
36. Nonlinear changes in delayed functional network topology in Alzheimer's disease: relationship with amyloid and tau pathology.
Mijalkov M; Veréb D; Canal-Garcia A; Hinault T; Volpe G; Pereira JB;
Alzheimers Res Ther; 2023 Jun; 15(1):112. PubMed ID: 37328909
[TBL] [Abstract][Full Text] [Related]
37. Dissecting the Contribution of Vascular Alterations and Aging to Alzheimer's Disease.
Janota C; Lemere CA; Brito MA
Mol Neurobiol; 2016 Aug; 53(6):3793-3811. PubMed ID: 26143259
[TBL] [Abstract][Full Text] [Related]
38. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
[TBL] [Abstract][Full Text] [Related]
39. [Cholesterol and Alzheimer's disease].
Kálmán J; Janka Z
Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
[TBL] [Abstract][Full Text] [Related]
40. Interactions between Beta-Amyloid and Pericytes in Alzheimer's Disease.
Li YY; Guo DD; Duan RN; Li Y
Front Biosci (Landmark Ed); 2024 Apr; 29(4):136. PubMed ID: 38682184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
